To confirm the implication of FGFR1 pathway in GBM radioresistance in vivo, we raised the hypothesis that FOXM1, MELK, GLI2, TWIST1, ZEB1 could be involved in the worse survival prognosis of patients treated for GBM with chemo-radiotherapy. This evidence concerns the gene FGFR1 and glioblastoma.